Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cyclerion Therapeutics, Inc. has filed 344 SEC EDGAR filings since 09 Oct 2018

SEC filing history

Showing 176-200 of 344 matching filings.

Per page
25
Current page
8
UPLOAD

UPLOAD filing

Filing date
21 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-403393

D filing

Filing date
17 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-257145

S-3

Filing date
16 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90979

SC 13DA

Filing date
07 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38787

8-K

Filing date
04 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 May 2021
Reporting date
21 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90979

SC 13D

Filing date
14 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38787

8-K

Filing date
04 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38787

DEFA14A

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38787

DEF 14A

Filing date
28 Apr 2021
Reporting date
24 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38787

8-K

Filing date
27 Apr 2021
Reporting date
27 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38787

8-K

Filing date
26 Apr 2021
Reporting date
21 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38787

8-K/A

Filing date
19 Mar 2021
Reporting date
18 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38787

8-K

Filing date
18 Mar 2021
Reporting date
18 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Mar 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90979

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90979

SCHEDULE 13/G FILING BY CYCLERION ON BEHALF OF MFN PARTNERS

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .